Center for biologics evaluation and research (cber), biologics effectiveness and safety (best) initiative: development of new and innovative methods for automated reporting for cber-regulated…
Ended Awarded Last action
- Contract number
- 75F40118D10032
- Awardee
-
Iqvia Government Solutions Inc. UEI T13YR5E14QY7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- FDA18223SOL1196210 Solicitation number
- Biologics Effectiveness and Safety (BEST) Initiative: Development of New and Innovative Methods for Automated Reporting for CBER-Regulated Products Award Notice · Posted May 25, 2018
- Last date to order 100% complete
- IDV ceiling
- $75,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Indefinite Delivery Contract (IDC) with ID 75F40118D10032 was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative. The $75 million multiple-award contract aims to develop new and innovative methods for automated reporting of CBER-regulated biological products.
Iqvia Government Solutions, a leading provider of healthcare data and analytics services to federal agencies, will deliver a range of data sources and analytical capabilities to support the FDA's post-market drug safety monitoring, regulatory decision-making, and public health initiatives. This includes access to outpatient prescription and patient-level drug utilization data, hospital drug data, over-the-counter drug data, biologics safety surveillance data, and mobile health software. Iqvia has also provided healthcare data and analytics services to other agencies such as the CDC and Department of Defense through various IDVs and grant sub-awards.
Description
Center for biologics evaluation and research (cber), biologics effectiveness and safety (best) initiative: development of new and innovative methods for automated reporting for cber-regulated biological products.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $10,000 |
Quick answers
Who was awarded contract 75F40118D10032?
75F40118D10032 was awarded to Iqvia Government Solutions Inc. by Food and Drug Administration (Department of Health and Human Services) on September 27, 2018.
How much is contract 75F40118D10032 worth?
75F40118D10032's own ceiling is $75,000,000.
Who can order from contract 75F40118D10032?
75F40118D10032 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75F40118D10032 part of a contract vehicle?
Yes. 75F40118D10032 is part of BEST Initiative - New and Innovative Methods for Automated Reporting.
Was contract 75F40118D10032 competed?
The extent of competition for 75F40118D10032 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV